NCT00525057 · OUTCOME

Number of Participants With Occurrence of Venous Thromboembolism

Dalteparin in Preventing DVT in Participants With Cancer · Source last updated 2021-01-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: COUNT_OF_PARTICIPANTS
Unit: Participants
Interval / dispersion: Not reported
Time frame: 4 weeks after surgery

What was measured

A secondary outcome was the occurrence of venous thrombolembolism in the post-operative period, to include both deep venous thrombosis in the lower extremity as well as pulmonary embolism.

Groups in this outcome

Interventional (Dalteparin, Metastatic)

Received dalteparin 5000 units daily postop, patients with metastatic disease.

Interventional (Dalteparin, Sarcoma)

Received dalteparin 5000 units daily postop, patients with primary sarcomas.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Interventional (Dalteparin, Metastatic)	25
Interventional (Dalteparin, Sarcoma)	25

Reported measurements

Deep venous thrombosis

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Interventional (Dalteparin, Metastatic)	1	Not reported	Not reported	Not reported	Not reported
Interventional (Dalteparin, Sarcoma)	0	Not reported	Not reported	Not reported	Not reported

Pulmonary embolism

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Interventional (Dalteparin, Metastatic)	0	Not reported	Not reported	Not reported	Not reported
Interventional (Dalteparin, Sarcoma)	0	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
1
group Id
OG001
value
0
title
Deep venous thrombosis
categories
measurements
group Id
OG000
value
0
group Id
OG001
value
0
title
Pulmonary embolism

denoms

counts
group Id
OG000
value
25
group Id
OG001
value
25
units
Participants

description

A secondary outcome was the occurrence of venous thrombolembolism in the post-operative period, to include both deep venous thrombosis in the lower extremity as well as pulmonary embolism.

groups

description
Received dalteparin 5000 units daily postop, patients with metastatic disease.
id
OG000
title
Interventional (Dalteparin, Metastatic)
description
Received dalteparin 5000 units daily postop, patients with primary sarcomas.
id
OG001
title
Interventional (Dalteparin, Sarcoma)

param Type

COUNT_OF_PARTICIPANTS

reporting Status

POSTED

time Frame

4 weeks after surgery

title

Number of Participants With Occurrence of Venous Thromboembolism

type

SECONDARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice